3/2
08:01 am
xlo
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/2
08:00 am
xlo
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
Medium
Report
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
3/2
07:30 am
xlo
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/12
02:35 am
xlo
Xilio Therapeutics prices $40M stock offering [Seeking Alpha]
Medium
Report
Xilio Therapeutics prices $40M stock offering [Seeking Alpha]
2/11
09:34 pm
xlo
Xilio Therapeutics Announces Pricing of Underwritten Offering
Medium
Report
Xilio Therapeutics Announces Pricing of Underwritten Offering
1/8
08:30 am
xlo
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
Low
Report
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
12/30
04:16 pm
xlo
Xilio Therapeutics (NASDAQ:XLO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Xilio Therapeutics (NASDAQ:XLO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/16
04:43 pm
xlo
Xilio Therapeutics (NASDAQ:XLO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Xilio Therapeutics (NASDAQ:XLO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.